Syndax Pharmaceuticals (SNDX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2024)
Syndax Pharmaceuticals (SNDX) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
-84.62% |
| Mar 31, 2024 |
-70.59% |
| Dec 31, 2023 |
-60.00% |
| Sep 30, 2023 |
-56.52% |
| Jun 30, 2023 |
-94.92% |
| Mar 31, 2023 |
-93.61% |
| Dec 31, 2022 |
-92.81% |
| Sep 30, 2022 |
-85.44% |
| Jun 30, 2022 |
54.22% |
| Mar 31, 2022 |
51.14% |
| Dec 31, 2021 |
44.79% |
| Sep 30, 2021 |
-26.17% |
| Jun 30, 2021 |
-29.96% |
| Mar 31, 2021 |
-32.05% |
| Dec 31, 2020 |
-31.67% |
| Sep 30, 2020 |
-29.61% |
| Jun 30, 2020 |
-27.52% |
| Mar 31, 2020 |
-26.00% |
| Dec 31, 2019 |
-24.66% |
| Sep 30, 2019 |
-23.23% |
